BRIEF

on AMOEBA (EPA:ALMIB)

AXPERA awarded for its innovation in biocontrol

Stock price chart of AMOEBA (EPA:ALMIB) showing fluctuations.

Amoéba, a French greentech company, has won the Bernard Blum Award 2025 Gold Medal for its AXPERA biocontrol solution. This award recognizes the company's innovation in combating fungal plant diseases. AXPERA stands out for its pioneering use of amoebae, offering a sustainable alternative to traditional chemical treatments.

This global recognition highlights Amoéba's commitment to developing environmentally friendly technologies spanning more than a decade. The solution has been tested on a variety of crops, particularly in Europe and the United States, demonstrating its effectiveness and reliability in real-world conditions.

In the United States, AXPERA has obtained approval from the US EPA, and efforts are underway in Europe and Brazil to expand its commercialization. These advances confirm AXPERA's potential to become a global benchmark in biocontrol.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AMOEBA news